Detailansicht

Wissensnetz

Person

Roland Kappler (1968-)

Name	Roland Kappler
Zeit	1968- (Lebensdaten)
Weitere Angaben	Diss. Fachbereich Biologie
Datensatztyp	Person
GND-Nummer	120737701
Datensatz-ID	120737701
Beteiligt an alle anzeigen Drug prioritization identifies panobinostat as a tailored treatment element for patients with metastatic hepatoblastoma Impact of BCL-2 Expression on Course of Disease in Neuroblastoma Genetic Evidence for Congenital Vascular Disorders in Patients with VACTERL Association Total Psoas Muscle Area as a Marker for Sarcopenia Is Related to Outcome in Children With Neuroblastoma Downregulation of SFRP1 is a protumorigenic event in hepatoblastoma and correlates with beta-catenin mutations Lymphatic Leakage after Surgery for Neuroblastoma: A Rare Complication? Overexpression of UHRF1 promotes silencing of tumor suppressor genes and predicts outcome in hepatoblastoma Activation of the Wnt/β-catenin pathway is common in wilms tumor, but rarely through β-catenin mutation and APC promoter methylation Low expression of N-myc downstream-regulated gene 2 (NDRG2) correlates with poor prognosis in hepatoblastoma IGFBP3 impedes aggressive growth of pediatric liver cancer and is epigenetically silenced in vascular invasive and metastatic tumors Charakterisierung genomischer und genetischer Veränderungen in neuroepithelialen Tumoren der Ratte

Hinweis

Die Betaversion beinhaltet noch nicht alle Funktionen und Informationen des Katalogs des DNB-Portals. Falls Sie Informationen vermissen oder ein Medium bestellen wollen, besuchen Sie bitte die entsprechende Seite im Katalog des DNB-Portals über folgenden Link:

Katalog der Deutschen Nationalbibliothek

Roland Kappler (1968-)

Drug prioritization identifies panobinostat as a tailored treatment element for patients with metastatic hepatoblastoma

Impact of BCL-2 Expression on Course of Disease in Neuroblastoma

Genetic Evidence for Congenital Vascular Disorders in Patients with VACTERL Association

Total Psoas Muscle Area as a Marker for Sarcopenia Is Related to Outcome in Children With Neuroblastoma

Downregulation of SFRP1 is a protumorigenic event in hepatoblastoma and correlates with beta-catenin mutations

Lymphatic Leakage after Surgery for Neuroblastoma: A Rare Complication?

Overexpression of UHRF1 promotes silencing of tumor suppressor genes and predicts outcome in hepatoblastoma

Activation of the Wnt/β-catenin pathway is common in wilms tumor, but rarely through β-catenin mutation and APC promoter methylation

Low expression of N-myc downstream-regulated gene 2 (NDRG2) correlates with poor prognosis in hepatoblastoma

IGFBP3 impedes aggressive growth of pediatric liver cancer and is epigenetically silenced in vascular invasive and metastatic tumors

Charakterisierung genomischer und genetischer Veränderungen in neuroepithelialen Tumoren der Ratte